CommercialCoverageHigh impact
BlueSpeak July 2026: Provider Education
Blue Cross and Blue Shield of Kansas City·MO · Dermatology, Endocrinology·Provider News
Effective date
Jul 1, 2026
We identified it
Jul 28, 2026
Summary
Blue KC is implementing multiple policy changes effective September 1, 2026 and July 1, 2026: (1) Phothera, an FDA-cleared phototherapy device, becomes an in-network DME option for chronic skin conditions using codes E0691-E0694; (2) Implantable CGM systems (codes 0446T, 0448T) are reimbursed under Provider Buy and Bill methodology; (3) New post-payment audit partnership with Cotiviti begins October 1, 2026; (4) All claims exceeding $1M require prepay review with medical records/itemized bills effective July 1, 2026; (5) Clinical edit denials for lab claims are increasing due to missing modifiers and unsupported diagnosis codes.
Action Required
IMMEDIATE ACTIONS: (1) By September 1, 2026: Billing team must update revenue cycle system to recognize E0691, E0692, E0693, E0694 as covered DME codes for Phothera when ordered for atopic dermatitis, cutaneous T-cell lymphoma, vitiligo, psoriasis, or chronic pruritus. MCG Guideline A-0255 must be referenced in prior authorization workflows. (2) By September 1, 2026: Billing team must update claims submission procedures for codes 0446T and 0448T to bundle implantable CGM sensor costs with procedure reimbursement under Provider Buy and Bill methodology. DO NOT separately bill through DME, specialty pharmacy, or manufacturer replacement programs. Ensure provider documentation reflects sensor was purchased and maintained as office inventory prior to implantation. (3) By July 1, 2026: Billing team must implement prepay review protocol for claims exceeding $1M. Establish process to submit medical records and itemized bills to fax 816-926-4258 BEFORE claim submission. All prepay reviews must include: itemized bill review, DRG review, claim data/financial accuracy review, never event/hospital-acquired condition review, and core/advanced clinical editing. (4) By October 1, 2026: Prepare for Cotiviti post-payment audits focused on: incorrect contracted rates, incorrect claim coordination, incorrect modifier reduction, incorrect units, duplicate payments, and coordination of benefits. Ensure billing documentation is audit-ready. (5) ONGOING: Referring providers must submit complete lab orders with correct primary diagnosis codes and required modifiers on ALL independent laboratory claims. Providers cannot change diagnosis codes after lab receipt, so errors must be prevented at order entry. Update provider communication templates with Blue KC Laboratory Medical Policies coverage criteria and medical necessity requirements. Implement provider education on required modifiers to prevent clinical edit denials. Consequences: Claims without proper modifiers/diagnosis codes will be denied; claims exceeding $1M without prepay documentation will be held; post-payment audits may result in payment recovery for identified errors.